MassIVE MSV000096787

Partial Public

GNPS - Sequential Target and Non-target for Global (STANG) metabolomics in a Single Injection to Discover Prognostic Biomarkers of Acute Ischemic Stroke

Subscribe Comment Reanalyze Spectra Add Reanalysis

Description

Non-targeted metabolomics by an LC-MS system offers the advantage of wide signal coverage, enabling the discovery of novel biomarkers. However, it suffers from a low identification rate and limitations due to incomplete databases and reliable bioinformatics software to handle large data sets. On the other hand, targeted metabolomics focuses on specific biomarkers, allowing for a more directed search but potentially limiting the exploration of other potential biomarkers. To address these challenges, we developed a novel method called Sequential Target And Non-target for Global metabolomics (STANG metabolomics) using the functionality of the triple quadrupole-linear ion trap mass spectrometer (Q-Trap MS). This method combines the capabilities of a triple quadrupole for a wide linear range of MRM scans and an ion trap for fast full-scan acquisition. Our approach enables the direct analysis of known metabolites while simultaneously recording mass spectrometry signals of non-targeted substances in the full-scan spectra, facilitating comprehensive biomarker identification. Currently, 448 metabolite targets have been built, and the STANG metabolomics approach was applied to discover prognostic biomarkers of acute ischemic stroke. We identified 32 biomarkers through targeted metabolomics and 83 candidates through non-targeted metabolomics. The top four markers with the highest AUC values are lithocholic acid (AUC=0.999), ursodeoxycholic acid (AUC=0.985), 3,4-Dihydroxyphenylglycol (AUC=0.836), and 4-Hydroxybenzaldehyde (AUC=0.807). This approach shortens sample analysis time, reduces data conversion, increases metabolite coverage, and improves analytical sensitivity and accuracy. The potential of the STANG metabolomics approach was evaluated in discovering prognostic biomarkers of stroke, demonstrating its value as a comprehensive tool for biomarker discovery and disease mechanism elucidation. [doi:10.25345/C5X34N43J] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Sequential Target and Non-target for Global metabolomics, Stroke, STANG ; DatasetType:Metabolomics

Contact

Principal Investigators:
(in alphabetical order) 		Chen, chao-jung, Graduate Institute of Integrated Medicine, Taiwan, ROC.
Submitting User: cjchen_01
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

Species

Instrument

Modifications

- Dataset Reanalyses

+ Dataset History

GNPS content goes here (MSV000096787 [task=25db4c7383c04de9a72fa82fae8c9efc])
Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.